We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$83B
AUM Growth
+$4.08B
(+5.2%)
Cap. Flow
-$2.07B
Cap. Flow
% of AUM
-2.5%
Top 10 Holdings %
Top 10 Hldgs %
13.18%
Holding
730
New
59
Increased
161
Reduced
398
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$550M |
| 2 |
Fidelity National Information Services
FIS
|
+$353M |
| 3 |
Global Payments
GPN
|
+$263M |
| 4 |
CVS Health
CVS
|
+$175M |
| 5 |
Devon Energy
DVN
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$433M |
| 2 |
Lowe's Companies
LOW
|
+$277M |
| 3 |
Oracle
ORCL
|
+$226M |
| 4 |
Progressive
PGR
|
+$220M |
| 5 |
Las Vegas Sands
LVS
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.96% |
| 2 | Healthcare | 15.3% |
| 3 | Industrials | 15.12% |
| 4 | Technology | 14.91% |
| 5 | Consumer Discretionary | 11.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Linde
LIN
$239B
| $2.71M | ﹤0.01% |
7,824
-796
| -9% | -$258K |
|
427
SM Energy
SM
$7.13B
| $2.67M | ﹤0.01% |
90,693
-49,876
| -35% | -$1.56M |
|
|
AVTA
428
DELISTED
Avantax, Inc. Common Stock
AVTA
| $2.65M | ﹤0.01% |
152,997
+24,457
| +19% | +$415K |
|
|
SF
429
Stifel
SF
$12.7B
| $2.63M | ﹤0.01% |
56,087
| – | – |
|
|
BNY
430
Bank of New York Mellon
BNY
$106B
| $2.63M | ﹤0.01% |
45,232
-30,748
| -40% | -$1.77M |
|
|
TA
431
DELISTED
TravelCenters of America LLC
TA
| $2.62M | ﹤0.01% |
50,698
-590
| -1% | -$31.9K |
|
432
Celestica
CLS
$38.1B
| $2.57M | ﹤0.01% |
230,941
+110,311
| +91% | +$1.14M |
|
433
AGCO
AGCO
$8.91B
| $2.56M | ﹤0.01% |
+22,079
| New | +$2.68M |
|
434
KBR
KBR
$4.75B
| $2.56M | ﹤0.01% |
53,790
-16,378
| -23% | -$723K |
|
435
S&P Global
SPGI
$127B
| $2.53M | ﹤0.01% |
5,367
-538
| -9% | -$246K |
|
436
Northern Oil and Gas
NOG
$2.18B
| $2.5M | ﹤0.01% |
121,356
+50,581
| +71% | +$1.13M |
|
437
National Bank Holdings
NBHC
$1.91B
| $2.47M | ﹤0.01% |
56,223
+3,538
| +7% | +$154K |
|
438
Heritage Financial
HFWA
$1.23B
| $2.46M | ﹤0.01% |
100,633
-1,221
| -1% | -$30.1K |
|
439
Apple Hospitality REIT
APLE
$3.93B
| $2.41M | ﹤0.01% |
149,070
+7,701
| +5% | +$122K |
|
440
Mastercard
MA
$496B
| $2.4M | ﹤0.01% |
6,674
| – | – |
|
441
Stryker
SYK
$133B
| $2.39M | ﹤0.01% |
8,933
-899
| -9% | -$236K |
|
442
Brookdale Senior Living
BKD
$3.64B
| $2.38M | ﹤0.01% |
+461,488
| New | +$2.88M |
|
|
HNGR
443
DELISTED
Hanger Inc.
HNGR
| $2.38M | ﹤0.01% |
131,256
-959
| -0.7% | -$17.8K |
|
444
UBS Group
UBS
$170B
| $2.37M | ﹤0.01% |
132,544
-8,872
| -6% | -$156K |
|
|
PFC
445
DELISTED
Premier Financial Corp. Common Stock
PFC
| $2.36M | ﹤0.01% |
76,427
+7,788
| +11% | +$245K |
|
446
Goodyear
GT
$2.08B
| $2.36M | ﹤0.01% |
110,733
+74,994
| +210% | +$1.56M |
|
|
447
Progressive
PGR
$129B
| $2.36M | ﹤0.01% |
22,958
-2,304,623
| -99% | -$220M |
|
448
Jefferies Financial Group
JEF
$13.1B
| $2.33M | ﹤0.01% |
62,859
| – | – |
|
|
TPC
449
Tutor Perini Cor
TPC
$4.3B
| $2.32M | ﹤0.01% |
187,836
-14,363
| -7% | -$192K |
|
450
Hope Bancorp
HOPE
$1.81B
| $2.32M | ﹤0.01% |
157,531
-1,765
| -1% | -$26.1K |
|
Similar funds
Boston Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Boston Partners held 730 positions worth $83B, up 5.2% from $78.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Boston Partners's Q4 2021 filing shows 59 new, 161 increased, 398 reduced and 45 closed positions. Its largest new stake was Keurig Dr Pepper: 15,605,496 shares worth $575M. The largest sale was Pfizer, an estimated $433M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q4 2021 buy was Keurig Dr Pepper: 15,605,496 shares worth $575M.
- Boston Partners added most to Fidelity National Information Services in Q4 2021, an estimated $353M increase.
- Boston Partners's biggest Q4 2021 reduction was Pfizer, cutting an estimated $433M.
- Boston Partners fully exited CyrusOne Inc Common Stock in Q4 2021, selling an estimated $137M.
- Boston Partners's ten largest holdings make up 13% of its $83B portfolio in Q4 2021.
- Boston Partners opened 59 new positions and closed 45 in Q4 2021.
- Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $83B.
Based on Boston Partners's 13F filing for Q4 2021, filed 4 Feb 2022.